Nasdaq Eligibility. As of the Effective Date, the Public Securities have been approved for listing on the Nasdaq Capital Markets (“NASDAQ”), subject to official notice of issuance and evidence of satisfactory distribution. There is and has been no failure on the part of the Company or any of the Company's directors or officers, in their capacities as such, to comply with (as and when applicable), and immediately following the effectiveness of the Registration Statement the Company will be in compliance with, the NASDAQ Marketplace Rules, as amended. To the Company’s knowledge, no proceedings have been instituted or threatened which would effect, and no event or circumstance has occurred since the Effective Date that is reasonably likely lead to proceedings to effect, the delisting of the Public Securities from NASDAQ. As of the Effective Date, the Company met all applicable requirements for listing on the Nasdaq.
Appears in 3 contracts
Samples: Underwriting Agreement (Arowana Inc.), Underwriting Agreement (Barington/Hilco Acquisition Corp.), Underwriting Agreement (Arowana Inc.)
Nasdaq Eligibility. As of the Effective Date, the Public Securities have been approved for listing on the Nasdaq Capital Markets (“NASDAQ”), subject to official notice of issuance and evidence of satisfactory distribution. There is and has been no failure on the part of the Company or any of the Company's directors or officers, in their capacities as such, to comply with (as and when applicable), and immediately following the effectiveness of the Registration Statement the Company will be in compliance with, the NASDAQ Marketplace Rules, as amended. To the Company’s knowledge, no proceedings have been instituted or threatened which would effect, and no event or circumstance has occurred since the Effective Date that is reasonably likely lead to proceedings to effect, the delisting of the Public Securities from NASDAQ. As of the Effective Date, the Company met all applicable requirements for listing on the Nasdaq.
Appears in 3 contracts
Samples: Underwriting Agreement (CB Pharma Acquisition Corp.), Underwriting Agreement (CB Pharma Acquisition Corp.), Underwriting Agreement (CB Pharma Acquisition Corp.)
Nasdaq Eligibility. As of the Effective Date, the Public Securities have been approved for listing on the Nasdaq Capital Markets (“NASDAQ”), subject to official notice of issuance and evidence of satisfactory distribution. There is and has been no failure on the part of the Company or any of the Company's directors or officers, in their capacities as such, to comply with (as and when applicable), and immediately following the effectiveness of the Registration Statement the Company will be in compliance with, the NASDAQ Marketplace Rules, as amended. To the Company’s knowledge, no proceedings have been instituted or threatened which would effect, and no event or circumstance has occurred since the Effective Date that is reasonably likely lead to proceedings to effect, the delisting of the Public Securities from NASDAQ. As of the Effective Date, the Company met all applicable requirements for listing on the Nasdaq.. [·], 2015
Appears in 1 contract
Samples: Underwriting Agreement (Barington/Hilco Acquisition Corp.)
